An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.
Oral Lipid Nanoparticle Drug Shields Against Colitis Cancer: Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In a recent study, scientists at Georgia State University’s Institute for Biomedical Sciences discovered a potential therapeutic approach for treating ulcerative colitis: oral delivery of lipid nanoparticles that target the colon with nucleic acids.
Nanotechnology Now - Press Release: Georgia State researchers discover novel way to treat IBD with lipid nanoparticles nanotech-now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nanotech-now.com Daily Mail and Mail on Sunday newspapers.
Georgia State Researchers Discover Novel Way to Treat IBD With Lipid Nanoparticles gsu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gsu.edu Daily Mail and Mail on Sunday newspapers.